Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Latest Market Insights for the Remicade Biosimilar Industry?

In recent times, the market size for remicade biosimilar has seen enormous growth. The market, which was valued at $3.95 billion in 2024, is anticipated to surge to $4.89 billion in 2025, yielding a compound annual growth rate (CAGR) of 23.8%. This robust growth in the historical period is a result of factors such as the introduction of remicade (infliximab), advancement in biotechnology, expiration of biologics patent, establishment of regulatory pathways, and the pressure of healthcare costs.

In the coming years, the Remicade biosimilar market is predicted to experience an explosive surge in its size. It is forecasted to escalate to $10.89 billion by 2029, with a compound annual growth rate (CAGR) of 22.2%. Factors like patent expirations, an increase in demand for affordable treatment options, development of the biosimilar pipeline, reimbursement policies and market consolidation can be credited for the projected growth during this period. Other significant trends for this forecast period include the prescribing habits of physicians, management of biosimilar life cycles, naming strategies for biosimilars, their interchangeability, and real-world evidence of biosimilars.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11952&type=smp

What Forces Are Driving The Growth Of The Remicade Biosimilar Industry?

The surge in the occurrence of autoimmune diseases is anticipated to fuel the expansion of the remicade biosimilar market. These types of diseases are when the body’s immune system inaccurately damages its own tissues and organs. Remicade biosimilars provide an effective therapeutic treatment to alleviate the symptoms and inflammation related to these conditions. For instance, in July 2023, based on data from Public Health Scotland, a national Scotland-based organization, the number of newly diagnosed patients with multiple sclerosis (MS) in 2022 rose to 87.2%, up from 85.7% in 2020, resulting in 491 new cases and culminating in a total of 6,359 cases in 2022. As a result, the surge in autoimmune diseases is contributing to the expansion of the remicade biosimilar market.

What Is The Overview Of Market Segmentation In The Remicade Biosimilar Industry?

The remicade biosimilar market covered in this report is segmented –

1) By Type: 100mg/10ml, 500mg/50ml

2) By Disease Indication: Ulcerative Colitis, Rheumatoid Arthritis, Ankylosing Spondylitis, Crohn’s Disease, Psoriatic Arthritis, Plaque Psoriasis

3) By Application: Blood Disorders, Oncology Diseases

Subsegments:

1) By 100 Mg/10 Ml: Vials For Injection, Prefilled Syringes

2) By 500 Mg/50 Ml: Vials For Injection, Prefilled Syringes

What Future Market Trends Are Projected For The Remicade Biosimilar Industry?

The rising trend of increased investments is becoming increasingly significant in the proteasome inhibitors market. Numerous large-scale companies operating within this sector are investing significantly in the development and commercialization of proteasome inhibitors. These inhibitors are essential for advancing research and introducing new treatments in the market. In a recent example, in September 2022, QLi5 Therapeutics GmbH, a Germany-based company that develops new-class proteasome inhibitors, secured an investment of $10.96 million (EUR 10 million). This investment was received from investors such as SV Investment and KHAN Technology Transfer Fund I, both Germany-based venture capital firms, in addition to Atinum Investment Co., Ltd. and Daol Investment & Securities Co., Ltd., both venture capitalist firms based in South Korea. The primary objective of these investments is to develop innovative proteasome inhibitors to treat cancer and inflammatory and autoimmune diseases. This funding will help QLi5 to further advance its unique pipeline of proteasome inhibitors to the commencement of clinical trials for various indications.

Who Are The Primary Players Operating Across The Global Remicade Biosimilar Market?

Major companies operating in the remicade biosimilar market include Novartis AG, Amgen Inc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Biogen Inc., Merck And Co. Inc., LG Chem Ltd., Nippon Kayaku Co. Ltd., Celltrion Inc., Nichi-iko Pharmaceutical Co. Ltd., Biocon Limited, Alvotech S.A., MabPharm Ltd., Genor Biopharma Co. Ltd, Shanghai Biomabs Pharmaceuticals Co. Ltd., Samsung Bioepis Co. Ltd., Biocad Biopharmaceutical Co, EPIRUS Biopharmaceuticals Inc., Ranbaxy Laboratories Limited, BioXpress Therapeutics SA, Mabion S.A

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/remicade-biosimilar-global-market-report

Which Region Offers The Most Growth Potential For The Remicade Biosimilar Market Through 2029?

Europe was the largest region in the remicade biosimilar market in 2024. The regions covered in the remicade biosimilar market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=11952&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model